(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 5th June, 2008)
Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)
New Delhi, the 5th June, 2008
ORDER
S.O.1339(E) – In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Eli Lilly and Company (I) Pvt. Ltd.
TABLE
| Sl. No. | Name of the Formulation | Pack Size | Existing Retail Price (Rs.) | Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any (Rs.) | Equivalent MRP*(inclusive of all taxes)(Rs.) |
|---|---|---|---|---|---|
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1 | Monocomponent Insulin Huminsulin 30/70 – 40 IU/ml Vial (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. A482791 Qty. 47396 Vials imp. Batch No. A482790 Qty. 47953 Vials imp. |
10ml Vial | 164.36 | 163.64 | 170.19 |
| 2 | Monocomponent Insulin Huminsulin 30/70 – 100 IU/ml Vial (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. A450486 Qty. 47083 Vials imp. Batch No. A450487 Qty. 27596 Vials imp. |
10ml Vial | 369.87 | 369.06 | 383.82 |
| 3 | Monocomponent Insulin Huminsulin Regular 100 IU/ml (Insulin Human Injection) Batch No. A416048E Qty. 25000 Cart. imp. |
3ml Cartridge | 203.11 | 203.11 | 211.23 |
| 4 | Monocomponent Insulin Huminsulin 30/70 – 100 IU/ml (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. HIM361 Qty. 17014 Vials imp. |
10ml Vial | 369.87 | 369.53 | 384.31 |
| 5 | Monocomponent Insulin Huminsulin NPH 100 IU/ml (Isophane Insulin Human Suspension) Batch No. HIN079A Qty. 7690 Vials imp. |
10ml Vial | 369.12 | 369.12 | 383.88 |
| 6 | Monocomponent Insulin Huminsulin 30/70 – 100 IU/ml Vial (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. HIM364A Qty. 5444 Vials imp. |
10ml Vial | 369.87 | 369.39 | 384.16 |
| 7 | Monocomponent Insulin Huminsulin Regular 100 IU/ml (Insulin Human Injection) Batch No. HIR075A Qty. 9140 Vials imp. |
10ml Vial | 369.12 | 369.12 | 383.88 |
| 8 | Monocomponent Insulin Huminsulin 30/70 – 100 IU/ml (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. A423658E Qty. 150000 Cartridges imp. |
3ml Cartridge | 203.11 | 203.11 | 211.23 |
| 9 | Monocomponent Insulin Huminsulin NPH 100 IU/ml (Isophane Insulin Human Suspension Batch No. A416051D Qty. 14145 Cartridges imp. |
3ml Cartridge | 203.11 | 203.05 | 211.17 |
| 10 | Monocomponent Insulin Huminsulin 30/70 – 100 IU/ml (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. A419826E Qty. 130585 Cartridges imp. Batch No. A423658H Qty. 24130 Cartridges imp. |
3ml Cartridge | 203.04 | 203.04 | 211.16 |
| 11 | Monocomponent Insulin Humalog Mix 25 100 IU/ml 25% Insulin Lispro and 75% Insulin Lispro protamine suspension, r-DNA origin Batch No. A4416073C Qty. 30345 Cartridges imp. |
3ml Cartridge | 397.81 | 397.28 | 413.17 |
*Subject to actual payment of Government levies/taxes, as applicable.
NOTE :
(a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
PN/101/2008/F
F.No. 8(11)/2008/D.P./NPPA-Div.II
(RAJIV WADHAWAN)
Deputy Director
National Pharmaceutical Pricing Authority
Last Page Updated: 03-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)